Treatment with tanshinone I led to a significant decrease in cellular ATP (Figure 6F) and a substantial increase in mitochondrial ROS in both pancreatic cancer cells (Figure 6G), suggesting that inhibition of PLA2G2A could impair mitochondrial function with a decrease in ATP production. The gene discussed is PLA2G2A; the disease is pancreatic neoplasm.